ADVANCED ENZYME TECHNOLOGIES
|
The Current P/S Ratio of ADVANCED ENZYME TECHNOLOGIES is 4.21.
| Share Price | ₹267.3 | Apr 01,2026 |
| Market Cap | ₹2,990.5 Cr | |
| Sales-TTM | ₹709.6 Cr | TTM-Consolidated Results |
| Price/Sales | 4.21x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ADVANCED ENZYME TECHNOLOGIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹2,990.5 Cr] as on Apr 01,2026
(/) Sales [ ₹709.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.21x ]
Thus, for ADVANCED ENZYME TECHNOLOGIES , the investors are currently willing to pay '4.21 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ADVANCED ENZYME TECHNOLOGIES !
The chart below summarizes the trend in P/S Ratio of ADVANCED ENZYME TECHNOLOGIES over the last five years.
Historical PS (Price/Sales) ratio chart of ADVANCED ENZYME TECHNOLOGIES
PS Ratio Performance Analysis for ADVANCED ENZYME TECHNOLOGIES
- ADVANCED ENZYME TECHNOLOGIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 5.91x.
- ADVANCED ENZYME TECHNOLOGIES 's operated at median p/e ratio of 5.96x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ADVANCED ENZYME TECHNOLOGIES 's p/e ratio peaked in Mar2021 at 7.68x.
- ADVANCED ENZYME TECHNOLOGIES 's p/e ratio hit its five-year low in Mar2023 of 4.79x.
How does ADVANCED ENZYME TECHNOLOGIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| ADVANCED ENZYME TECHNOLOGIES | 709.6 | 4.21 | 2,990.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.30 | 414,713.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 15.20 | 156,811.0 |
| CIPLA LTD | 28,351.1 | 3.41 | 96,602.7 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 10.91 | 139,052.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 2.91 | 100,927.0 |
| MANKIND PHARMA LTD | 13,914.1 | 5.94 | 82,613.1 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.33 | 86,883.3 |
| LUPIN LTD | 26,150.5 | 3.97 | 103,944.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.35 | 77,949.4 |
| ABBOTT INDIA LTD | 6,824.1 | 8.25 | 56,293.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ADVANCED ENZYME TECHNOLOGIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.35x |
| Max industry PS | 15.20x |
| Median industry PS | 4.21x |
| Average industry PS | 6.16x |
You may also like the below Video Courses